Thus, NGR-TNF can engage high-avidity interactions with TNF-receptors and CD13 on cells that express both types of receptors, as it occurs in endothelial cells of the tumor vasculature, but not in normal vessels (which lack CD13) [13]. The gene discussed is TNF; the disease is neoplasm.